Financhill
Sell
50

ARWR Quote, Financials, Valuation and Earnings

Last price:
$68.58
Seasonality move :
40.49%
Day range:
$65.40 - $71.50
52-week range:
$9.57 - $71.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
11.04x
P/B ratio:
19.99x
Volume:
5.1M
Avg. volume:
2.6M
1-year change:
190.55%
Market cap:
$9.3B
Revenue:
$829.4M
EPS (TTM):
-$0.07

Earnings Data

Next earnings date for ARWR
Feb 09
2026
Most recent earnings per share
-$0.18
Missed by $0.02
(Nov 25/2025)
Consensus Estimate
-$0.16
(Nov 25/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ARWR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/09/2026 Q4 $244.9M -- -- -$0.10 --
11/25/2025 Q3 $157.3M $256.5M -$0.18 -$0.16 -$0.02
08/07/2025 Q2 $29M $27.8M -$1.26 -$1.10 -$0.16
05/12/2025 Q1 $116.3M $542.7M $2.75 -$0.46 $3.22
02/10/2025 Q4 $19.1M $2.5M -$1.39 -$0.72 -$0.66
11/26/2024 Q3 $58.9M -- -$1.37 -$0.92 -$0.45
08/08/2024 Q2 $37.1M -- -$1.38 -$0.59 -$0.79
05/09/2024 Q1 $56.8M -- -$1.02 -$0.20 -$0.82
02/06/2024 Q4 $29.6M $3.6M -$1.24 -$0.83 -$0.41
11/29/2023 Q3 -- $16.1M -$1.02 -- --
08/07/2023 Q2 -- $15.8M -$0.96 -- --
05/02/2023 Q1 -- $146.3M $0.45 -- --
02/06/2023 Q4 -- $62.5M -$0.39 -- --
11/28/2022 Q3 -- $31.6M -$0.81 -- --
08/04/2022 Q2 -- $32.4M -$0.68 -- --
05/10/2022 Q1 -- $151.8M $0.41 -- --
02/02/2022 Q4 -- $27.4M -$0.60 -- --
11/22/2021 Q3 -- $38.3M -$0.61 -- --
08/05/2021 Q2 -- $45.9M -$0.29 -- --
05/04/2021 Q1 -- $32.8M -$0.26 -- --
02/04/2021 Q4 -- $21.3M -$0.20 -- --
11/23/2020 Q3 -- $7.6M -$0.47 -- --
08/05/2020 Q2 -- $27.4M -$0.13 -- --
05/07/2020 Q1 -- $23.5M -$0.20 -- --
02/05/2020 Q4 -- $29.5M -$0.03 -- --
11/25/2019 Q3 -- $43.3M $0.12 -- --
08/05/2019 Q2 -- $42.7M $0.21 -- --
05/08/2019 Q1 -- $48.1M $0.24 -- --
02/07/2019 Q4 -- $34.7M $0.13 -- --
12/11/2018 Q3 -- $11.3M -$0.12 -- --
08/07/2018 Q2 -- $727.4K -$0.18 -- --
05/08/2018 Q1 -- $650.1K -$0.18 -- --
02/09/2018 Q4 -- $3.5M -$0.18 -- --
12/12/2017 Q3 -- $8.7M -$0.14 -- --
08/03/2017 Q2 -- $9.3M -$0.07 -- --
05/03/2017 Q1 -- $9M -$0.08 -- --
02/06/2017 Q4 -- $4.4M -$0.17 -- --
12/14/2016 Q3 -- $31.2K -$0.34 -- --
08/09/2016 Q2 -- $39.6K -$0.32 -- --
05/10/2016 Q1 -- $43.8K -$0.35 -- --
02/09/2016 Q4 -- $43.8K -$0.32 -- --

Arrowhead Pharmaceuticals, Inc. Earnings Questions

  • How Much did Arrowhead Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Arrowhead Pharmaceuticals, Inc. reported $256.5M worth of top line sales in its most recent quarter.

  • Did Arrowhead Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Arrowhead Pharmaceuticals, Inc. announced earnings per share of -$0.18 which represents a miss of analyst forecast a -$0.16 per share.

  • Is Arrowhead Pharmaceuticals, Inc. Profitable?

    Arrowhead Pharmaceuticals, Inc. reported $250.1M that represents $1.84 per share over the last quarter.

  • What is the Analyst Consensus for Arrowhead Pharmaceuticals, Inc. EPS Next Year?

    Arrowhead Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$0.01 per share to -$0.03 per share next year representing a decrease of -25481.23%.

  • When is Arrowhead Pharmaceuticals, Inc.'s Earnings Date?

    Arrowhead Pharmaceuticals, Inc.'s next earnings date is February 9, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
67
GPCR alert for Dec 9

Structure Therapeutics, Inc. [GPCR] is up 102.52% over the past day.

Buy
62
SMX alert for Dec 9

SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.

Buy
90
KYMR alert for Dec 9

Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock